|
COPYRIGHT 2004 International Medical News Group
Certain women taking nevirapine, including those with high CD4 counts or who are pregnant and receiving chronic HIV infection treatment, have a significantly increased risk of hepatotoxicity, Dr. Kirk V Shepard of Boehringer Ingelheim Pharmaceuticals said in a "Dear Health Care Professional" letter.
In the letter, posted on the...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
